Here's the live share price of Aurobindo Pharma along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Source: Dion Global
Source: Dion Global
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Aurobindo Pharma | -3.24 | 7.82 | 16.12 | 33.68 | 38.79 | 28.71 | 10.76 |
| Sun Pharmaceutical Industries | 1.61 | 8.29 | 16.95 | 11.42 | 16.36 | 22.76 | 23.67 |
| Divi's Laboratories | 1.06 | 2.91 | 11.65 | 5.30 | -0.13 | 23.33 | 8.29 |
| Torrent Pharmaceuticals | 2.72 | 9.68 | 17.75 | 23.98 | 46.60 | 36.78 | 26.59 |
| Cipla | -1.35 | 4.54 | 17.01 | -1.86 | -2.61 | 12.28 | 8.44 |
| Zydus Lifesciences | 0.83 | 4.79 | 25.68 | 28.55 | 18.16 | 25.56 | 12.26 |
| Lupin | 0.84 | 11.04 | 7.04 | 14.03 | 31.71 | 40.48 | 16.73 |
| Mankind Pharma | -0.18 | 6.53 | 21.54 | 13.46 | -0.66 | 13.54 | 12.15 |
| Dr. Reddy's Laboratories | -9.39 | -2.06 | 1.10 | 2.46 | -1.09 | 6.50 | 2.55 |
| Laurus Labs | -0.50 | 10.75 | 39.72 | 47.17 | 93.36 | 62.43 | 17.77 |
| Biocon | -1.71 | 1.18 | 20.18 | 12.61 | 12.50 | 18.09 | 1.58 |
| Alkem Laboratories | 1.87 | 7.17 | 4.32 | -3.30 | 19.87 | 17.66 | 11.07 |
| Glenmark Pharmaceuticals | 3.00 | 6.16 | 5.23 | 12.78 | 19.47 | 50.75 | 28.25 |
| Abbott India | 4.93 | 2.44 | 5.26 | -4.54 | -21.63 | 4.97 | 9.43 |
| Ipca Laboratories | 0.33 | 9.33 | 22.71 | 16.91 | 23.86 | 33.26 | 11.05 |
| Anthem Biosciences | -1.85 | -1.35 | 1.43 | 22.32 | 3.44 | 1.13 | 0.68 |
| Ajanta Pharma | 1.02 | 9.34 | 19.84 | 22.89 | 29.80 | 33.64 | 18.48 |
| GlaxoSmithKline Pharmaceuticals | 1.79 | 12.01 | 1.77 | 1.54 | -25.06 | 20.37 | 10.22 |
| Gland Pharma | 0.71 | 9.26 | 42.43 | 45.49 | 34.48 | 31.69 | -7.19 |
| J B Chemicals & Pharmaceuticals | 3.63 | 11.13 | 22.22 | 30.51 | 51.87 | 28.01 | 21.71 |
Source: Dion Global
Over the last one year, Aurobindo Pharma has gained 38.79% compared to peers like Sun Pharmaceutical Industries (16.36%), Divi's Laboratories (-0.13%), Torrent Pharmaceuticals (46.60%). From a 5 year perspective, Aurobindo Pharma has underperformed peers relative to Sun Pharmaceutical Industries (23.67%) and Divi's Laboratories (8.29%).
Source: Dion Global
| Day | SMA | EMA |
|---|---|---|
| 5 | 1,582.79 | 1,573.42 |
| 10 | 1,567.61 | 1,559.78 |
| 20 | 1,512.96 | 1,530.77 |
| 50 | 1,481.7 | 1,474.88 |
| 100 | 1,377.57 | 1,402.4 |
| 200 | 1,269.72 | 1,319.61 |
Source: Dion Global
In the latest quarter, Aurobindo Pharma remained same as its previous close in promoter holding, while DII stake decreased to 25.87%, FII holding rose to 15.24%, and public shareholding moved up to 7.08% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
|---|---|---|---|
| 1,33,44,745 | 1.96 | 1,903.49 | |
| 66,52,259 | 7.26 | 948.88 | |
| 53,67,895 | 9.44 | 765.68 | |
| 53,56,608 | 1.94 | 764.07 | |
| 42,57,303 | 7.92 | 607.26 | |
| 40,07,877 | 2.55 | 571.68 | |
| 30,04,373 | 6.13 | 428.54 | |
| 27,00,437 | 0.37 | 385.19 | |
| 21,60,032 | 1.08 | 308.11 | |
| 19,76,168 | 8.23 | 281.88 |
Source: Dion Global
* Excluding Index & Arbitrage Funds
Date Time | Announcement |
|---|---|
| Jul 10, 2026, 06:33 PM IST IST | Aurobindo Pharma - Announcement under Regulation 30 (LODR)-Acquisition |
| Jul 02, 2026, 09:55 PM IST IST | Aurobindo Pharma - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 |
| Jul 02, 2026, 04:09 PM IST IST | Aurobindo Pharma - Completion Of Transfer Of Company'S Domestic Branded Generic Pharmaceutical Formulations Products Business |
| Jun 30, 2026, 03:24 PM IST IST | Aurobindo Pharma - Announcement under Regulation 30 (LODR)-Updates on Acquisition |
| Jun 27, 2026, 04:06 PM IST IST | Aurobindo Pharma - Completion Of US FDA Inspection At Auroactive Pharma Private Limited, A Wholly Owned Subsidiary Of The Com |
Source: Dion Global
Aurobindo Pharma Ltd. is a Public Limited Listed company incorporated on 26/12/1986 and has its registered office in the State of Telangana, India. Company's Corporate Identification Number(CIN) is L24239TG1986PLC015190 and registration number is 015190. Currently Company is involved in the business activities of Manufacture of other pharmaceutical and botanical products like hina powder etc.. Company's Total Operating Revenue is Rs. 11171.72 Cr. and Equity Capital is Rs. 58.08 Cr. for the Year ended 31/03/2026.
Source: Dion Global
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Aurobindo Pharma is ₹1,567.60 as on Jul 10, 2026.
The Aurobindo Pharma is operating in the Pharmaceuticals and health care Sector. It is classified as a Largecap stock on the BSE.
The market cap of Aurobindo Pharma is ₹91,046.46 Cr as on Jul 10, 2026.
Today’s highest and lowest price of Aurobindo Pharma are ₹1,581.00 and ₹1,543.70.
The 52-week high/low is the highest and lowest price at which Aurobindo Pharma stock has traded in the past 52-week or nearly a year. The 52-week high of Aurobindo Pharma is ₹1,636.00 and 52-week low of Aurobindo Pharma is ₹1,017.00 as on Jul 10, 2026.
The Aurobindo Pharma has shown returns of -1.19% over the past day, 7.82% for the past month, 16.12% over 3 months, 38.79% over 1 year, 28.71% across 3 years, and 10.76% over 5 years.
P/E ratio of and PB ratio of Aurobindo Pharma are 24.39 and 2.40 on Jul 10, 2026. While the company gives a dividend yield of 0.26 per annum.
Source: Dion Global